NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
Back to search
Official data from USPTO
THE DEPRESCRIBING PHARMACIST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE DEPRESCRIBING PHARMACIST
ST13
US500000097872309Class
44
Filing
97872309
Registration
7415975
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
06/11/2024
Trademark type
Word
Nice classes
44
Filing date
04/04/2023
Registration date
06/11/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
04/04/2023
First use in commerce
04/04/2023
Drawing code
4
Owner type
03
Owner location
Durham, NC
Examiner
CHOE, JULIE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
GeriatRx, Inc.
Representatives
Natori Arrindell LEGALLUXE LAW PLLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medication counseling; Telemedicine services; Wellness and health-related consulting services; Providing medical information in the field of medication managementmedication safety and educationgeriatric pharmacologyidentification of potentially inappropriate medications for older adults and drug interaction assessmentspatient advocacy and consultancy services around procurement and administration of medicine in the geriatric community
Publications
History of USPTO decisions and trademark events.
16 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/11/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/02/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/02/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/30/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/30/2023
GNRT
NON-FINAL ACTION E-MAILED
12/30/2023
CNRT
NON-FINAL ACTION WRITTEN
12/30/2023
DOCK
ASSIGNED TO EXAMINER
12/29/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/27/2023
NWAP
NEW APPLICATION ENTERED
04/07/2023
Continuous trademark protection
Get notified about every new filing that threatens THE DEPRESCRIBING PHARMACIST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.